Penetration of clarithromycin in experimental pleural empyema model fluid

Respiration

Volumn 72, Issue 3, 2005, Pages 296-300

  Liapakis, I E ^a,b   Light, R W ^b   Pitiakoudis, M S ^a   Karayiannakis, A J ^a   Giamarellos Bourboulis, E J ^c   Ismailos, G ^d   Anagnostoulis, S ^a   Simopoulos, C E ^a   Bouros, D E ^a,e  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b VANDERBILT UNIVERSITY   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d Elpen SA Pharmaceuticals   (Greece)

^e University General Hospital   (Greece)

Author keywords

Antibiotics; Clarithromycin; Escherichia coli; Pleural effusion; Pleural empyema, experimental; Pleural infection; Turpentine

Indexed keywords

CLARITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; ESCHERICHIA COLI; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; RABBIT; THORACOCENTESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BODY FLUIDS; CLARITHROMYCIN; DISEASE MODELS, ANIMAL; EMPYEMA, PLEURAL; INFUSIONS, INTRAVENOUS; MALE; PLEURA; RABBITS; REFERENCE VALUES; SODIUM CHLORIDE;

EID: 22144466597     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085371     Document Type: Article

References (23)

1. Light RW, Girard WM, Jenkinson SG: The incidence and significance of parapneumonic effusions. Am J Med 1980;69:507-512.
2. Bouros D, Hamm H: Infectious pleural effusions. Eur Respir Monogr 2002;22:204-218.
3. Sasse S, Nguyen T, Texeira LR, Light RW: The utility of daily therapeutic thoracentecis for the treatment of early empyema. Chest 1999;116:1703-1708.
4. Sasse S, Nguyen T, Mulligan M, Nai-San W, Mahutte K, Light RW: The effects of early chest tube placement on empyema resolution. Chest 1997;111:1679-1683.
5. Alemán C, Alegre J, Segura RM, Armadans L, Suriñach JM, Varela E, Soriano T, Recio J, deSevilla TM: Polymorphonuclear elastase in the early diagnosis of complicated pyogenic pleural effusions. Respiration 2003;70:462-467.
6. Martínez García MA, E. Viedma E, Perpiñá Tordera M, Sanchis-Aldás JL: Repeated thoracentesis: An important risk factor for eosinophilic pleural effusion? Respiration 2003;70:82-86.
7. Alexandrakis MG, Kyriakou D, Alexandraki R, Pappa KA, Antonakis N, Bouros D: Pleural interleukin-1 in differentiating transudates and exudates: Comparative analysis with other biochemical parameters. Respiration 2002;69:201-206.
8. Bouros D, Schiza S, Siafakas N: Fibrinolytics in the treatment of parapneumonic effusions. Monaldi Arch Chest Dis 1999;54:258-263.
9. Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP: Miliary tuberculosis as a cause of acute empyema. Respiration 2003;70:529-532.
10. Liapakis IE, Kottakis I, Tzatzarakis MN, Tsatsakis AM, Pitiakoudis MS, Ypsilantis P, Light RW, Simopoulos CE, Bouros D: Penetration of newer quinolones in the empyema fluid. Eur Respir J 2004;24:466-470.
11. Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW: Antibiotic levels in empyemic pleural fluid. Chest 2000;117:1734-1739.
12. Liapakis IE, Kottakis I, Light RW, Bouros D: Pharmacokinetics and pharmacodynamics in the pleural space; in Bouros D (ed): Pleural Diseases. New York, Dekker, 2004, pp 999-1008.
13. Sasse S, Causing L, Mulligan M: Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996;109:1043-1048.
14. Sahn SA, Potts DE: Turpentine pleurisy in rabbits: A model of pleural fluid acidosis and low pleural fluid glucose. Am Rev Resp Dis 1978;118:893-901.
15. Chandler TM, Mc Coskey EH, Byrd JR RP, Roy TM: Comparison of the use and accuracy of methods for determining pleural fluid pH. South Med J 1999;92:214-217.
16. Sastre Toraño J, Guchelar HJ: Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl chloride and fluorescence detection. J Chromatogr 1998;720:89-97.
17. Drusano GL, Craig WA: Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997;9(suppl 3):38-44.
18. Zuckerman JM: The newer macrolides: Azithromycin and clarithromycin. Infect Dis Clin North Am 2000;14:449-462.
19. Strahilevitz J, Lev A, Levi I, Fridman E, Rubinstein E: Experimental pneumococcal pleural empyema model: The effect of moxifloxacin. J Antimicrob Chemother 2003;51:665-669.
20. Taryle DA, Good JT Jr, Morgan EJ III et al: Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 1981;7:171-177.
21. Thys JP, Vanderhoeft P, Herchuelz A, et al: Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 1988;93:530-532.
22. Sakuma T, Kubo H, Tanita T, Koike K, Fujimura S: Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection. J Thorac Cardiovasc Surg 1994;107:955-957.
23. Light RW: Pleural diseases, 4th ed. Baltimore, Williams & Wilkins, 1995, pp 1-6.